Reliance Industries, Cancer genome sequencing
Strand Life Sciences, a Reliance subsidiary, Launches Pioneering Blood-based Test for Early Detection of Multiple Cancers
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers. Called CancerSpot,
Mukesh Ambani, a name that has become synonymous with unparalleled success and innovation, is one of the most influential ...
Indian shares closed higher on Monday, led by gains in heavyweights such as Reliance Industries, as the recent decline ...
The Nifty50 chart is showing early signs of a potential reversal, and when we connect the dots with large-cap stocks like ...
Central government's decision to abolish windfall tax may help the oil companies like Reliance and ONGC, market has already ...
Reliance Industries Ltd is quoting at Rs 1323.95, up 1.13% on the day as on 12:49 IST on the NSE. The stock is up 9.41% in last one year as compared to a 18.09% gain in NIFTY and a 25.14% gain in the ...
Reliance Industries’ shares rose over 2% on BSE following the announcement of its subsidiary acquiring a 21% stake in ...
Reliance Industries ( Mumbai International) has taken delivery of its first E175, VT-JMR (msn 17000976), ch-aviation research ...
Shares of Reliance Industries Ltd. 500325 inched up 0.60% to 1,295.55 Indian rupees Tuesday, on what proved to be an ...
Reliance Industries Limited (RIL) has once again been ranked as the most visible corporate entity in India, achieving a News ...
Digital Connexion, formerly known as BAM Digital Realty, currently has two data centers, located in the country’s financial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback